[{"Assets_0_Q2_USD":104266000.0,"CommonStockSharesOutstanding_0_Q2_shares":705273.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-10443000.0,"NetIncomeLoss_1_Q2_USD":-13557000.0,"NetIncomeLoss_2_Q2_USD":-19514000.0,"StockholdersEquity_0_Q2_USD":-34940000.0,"Ticker":"MIRM","CIK":"1759425","name":"MIRUM PHARMACEUTICALS, INC.","OfficialName":"Mirum Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"824673616.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190828"}]